UNITED STATES OF AMERICA —Venture lending activity in the medical technology sector continues to demonstrate resilience as specialized lenders capital-fund growth-stage healthcare developers. In the latest transaction, Horizon Technology Finance Corporation provided a $15 million senior credit line to neurorehabilitation device maker Bioness Medical, Inc., securing $10 million in initial capital funding at the close of the deal with an additional $5 million available to support future growth milestones.
This capital infusion is structured to advance the commercial reach and product development pipeline of therapeutic systems designed for stroke, spinal cord injury, and neurological recovery. Bioness Medical develops and commercializes FDA-approved rehabilitation systems, including functional electrical stimulation, neuromodulation, and robotic gait training technologies utilized across acute hospital settings, outpatient clinics, and home care environments. The company is headquartered in the United States and operates as a portfolio entity under private equity firm Accelmed Partners.
The agreement underscores an increasing reliance on venture debt among mid-stage life sciences firms seeking non-dilutive financing alternatives to navigate capital-intensive commercialization phases. Non-bank credit facilities offer growing medical technology firms the liquidity required to expand clinical adoption and global distribution without compromising equity structures during macro-level fundraising adjustments.
From an institutional perspective, the transaction reflects sustained credit provider confidence in clinically validated healthcare technologies with established reimbursement frameworks. Lenders specializing in venture debt continue to prioritize healthcare targets that display strong intellectual property portfolios, diversified product lines across multiple care settings, and strong private equity backing. For institutional investors and commercial lenders, capital deployments in neurorehabilitation highlight stable market demand driven by aging global demographics and a shift toward technologically augmented physical therapy solutions.
Horizon Technology Finance Corporation is a specialty finance firm that offers secured debt investments to venture capital and private equity-backed companies in technology, life sciences, and healthcare information sectors. External management for the firm is conducted by an affiliate of Monroe Capital, a global private credit asset manager focused on direct lending and structured capital solutions.
